The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

NCT00097344 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

842

Enrollment

INDUSTRY

Sponsor class

Stopped Identical study Biomed 777-CLP-029 did not meet superiority endpoint

Conditions

Breast Neoplasms
Neoplasms, Hormone-Dependent

Interventions

DRUG: Atamestane
DRUG: Toremifene
DRUG: Letrozole
DRUG: Aromatase inhibition
DRUG: Estrogen receptor blocker
PROCEDURE: Hormone therapy
PROCEDURE: Endocrine therapy
PROCEDURE: Antiestrogen therapy

Sponsor

Intarcia Therapeutics